← Back to Clinical Trials
Recruiting NCT05922007

NCT05922007 The Effect of Chronic Pain and Its Treatment on Quality of Life and Physical Activity

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT05922007
Status Recruiting
Phase
Sponsor University Hospital Ostrava
Condition Chronic Pain
Study Type OBSERVATIONAL
Enrollment 150 participants
Start Date 2023-07-01
Primary Completion 2025-12

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age 65 Years
Study Type OBSERVATIONAL
Interventions
Validation of the QuestionnaireProspective quantitative study - questionnaire survey

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 150 participants in total. It began in 2023-07-01 with a primary completion date of 2025-12.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Chronic pain is pain whose duration usually exceeds a period of three months and standard treatment is ineffective. This pain brings many changes in physical and psychological functioning to the individual and can even lead to a reduction in the quality of life. The main goal of the project is to determine the impact of pain and treatment on the quality of life and patterns of physical activity in patients with chronic pain. Furthermore, evaluate specific changes in quality of life, disability, physical activity, BMI, and body composition after the application of therapeutic and educational measures. Another goal is to validate an assessment tool for assessing the activity patterns of patients with chronic pain. In the first phase, the Czech version of the Patterns of Activity Measures-Pain scale (POAM-P/CZ) will be validated to assess the activity patterns of individuals with chronic pain. Subsequently, a prospective observational study will be carried out with the aim of comparing differences in quality of life, disability, activity patterns, BMI (body composition), and psychosocial variables after the application of targeted treatment measures and educational interventions. The subjective assessment of pain will be supplemented by the assessment of the Analgesia Nociception Index. The results of the project can contribute to the development of effective long-term strategies for the optimization of educational programs to support the self-management of chronic pain and the specific focus of health care.

Eligibility Criteria

Inclusion Criteria: * Patient with pain lasting at least 3 months * Age 18-65 years * Diagnosis of back pain, joint pain in arthrosis, postoperative and post-traumatic pain, and pain in rheumatic diseases * Czech language competency * Consent to the research investigation Exclusion Criteria: * Severe sight or hearing impairment or other illness that does not allow filling in the questionnaires * Oncological disease

Contact & Investigator

Central Contact

Jiří Hynčica

✉ jiri.hyncica@fno.cz

📞 0042059737

Principal Investigator

Andrea Polanská, PhDr., MBA

STUDY CHAIR

University Hospital Ostrava

Frequently Asked Questions

Who can join the NCT05922007 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, up to 65 Years, studying Chronic Pain. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT05922007 currently recruiting?

Yes, NCT05922007 is actively recruiting participants. Contact the research team at jiri.hyncica@fno.cz for enrollment information.

Where is the NCT05922007 trial being conducted?

This trial is being conducted at Ostrava, Czechia.

Who is sponsoring the NCT05922007 clinical trial?

NCT05922007 is sponsored by University Hospital Ostrava. The principal investigator is Andrea Polanská, PhDr., MBA at University Hospital Ostrava. The trial plans to enroll 150 participants.

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology